SAV-IOL is a Swiss company dedicated to providing optical solutions to fully restore the accommodative function of the eye after the cataract surgery. Over the years, SAV-IOL has developed a worldwide presence along with an ambitious R&D portfolio and has launched innovative intraocular lenses showing its capacity to integrate advanced concepts into tangible products that match with the market demand. To pursue its mission and continue to deliver high added value to the ophthalmic market, SAV-IOL is open for new investors to support its ongoing growth and development.